Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04729933 · ClinicalTrials.gov registry record · NA
Implantation of a Permanent Interatrial Shunt to Reduce Left Atrial Filling Pressures Following MitraClip
A NA study of Heart Failure and Mitral Regurgitation, sponsored by samir kapadia.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT04729933: Active NA study of Heart Failure and Mitral Regurgitation, sponsored by samir kapadia.
NCT04729933 is a NA study of Heart Failure and Mitral Regurgitation that is active but no longer recruiting, run by samir kapadia. The registered enrollment target is 10 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04729933, a NA study of Heart Failure and Mitral Regurgitation, is active but no longer recruiting, sponsored by samir kapadia.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an investigator initiated, prospective study to demonstrate the safety and feasibility of implantation of the V-Wave Interatrial Shunt System (herein called the "V-Wave Shunt" in patients immediately following percutaneous mitral valve repair using the MitraClip system.
Conditions Studied
Interventions
- DEVICE V-Wave Shunt Placement
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-03-11 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04729933
The ClinicalTrials.gov registry entry for NCT04729933 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (100% lower). The listed sponsor is samir kapadia, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which V-Wave Shunt Placement is the first listed.
NCT04729933 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04729933 about?
NCT04729933 is a clinical study titled "Implantation of a Permanent Interatrial Shunt to Reduce Left Atrial Filling Pressures Following MitraClip". This is an investigator initiated, prospective study to demonstrate the safety and feasibility of implantation of the V-Wave Interatrial Shunt System (herein called the "V-Wave Shunt" in patients immediately following percutaneous mitral valve repair using the MitraClip system.
What is the current status of trial NCT04729933?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2021-03-11. Estimated completion is 2027-12-31.
What conditions does trial NCT04729933 study?
This clinical trial studies the following conditions: Heart Failure, Mitral Regurgitation.
What interventions are being tested in trial NCT04729933?
The interventions under investigation include: V-Wave Shunt Placement (DEVICE).
Who is sponsoring clinical trial NCT04729933?
This trial is sponsored by samir kapadia, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04729933 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.